Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 62, Issue 1, Pages 59-70
Publisher
Wiley
Online
2012-09-18
DOI
10.1111/his.12033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Prevalence of Loss of Expression of DNA Mismatch Repair Proteins in Primary Epithelial Ovarian Tumors
- (2012) Fang-I Lu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Transitional Cell Carcinoma of the Ovary is Related to High-grade Serous Carcinoma and is Distinct From Malignant Brenner Tumor
- (2012) Rola H. Ali et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas
- (2012) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural history and outcome of mucinous carcinoma of the ovary
- (2011) Maria B. Schiavone et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Somatic Mutations of PPP2R1A in Ovarian and Uterine Carcinomas
- (2011) Ie-Ming Shih et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting the Extracellular Signal-Regulated Kinase Pathway in Cancer Therapy
- (2011) Michiaki Kohno et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
- (2011) M. S. Anglesio et al. CLINICAL CANCER RESEARCH
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. JOURNAL OF PATHOLOGY
- Low-grade serous carcinomas of the ovary contain very few point mutations
- (2011) Siân Jones et al. JOURNAL OF PATHOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
- (2011) Michael P. Stany et al. PLoS One
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Morphologic Spectrum of Immunohistochemically Characterized Clear Cell Carcinoma of the Ovary
- (2010) Deborah DeLair et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers
- (2010) K. D. Swenerton et al. ANNALS OF ONCOLOGY
- Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary
- (2010) Taymaa May et al. GYNECOLOGIC ONCOLOGY
- The Fallopian Tube
- (2010) Shannon Salvador et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
- (2010) Helen J. Mackay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
- (2010) Ali Dastranj Tabrizi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
- (2010) Yvette Drew et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase
- (2010) Ann Smith Sehdev et al. MODERN PATHOLOGY
- High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
- (2010) Michael H Roh et al. MODERN PATHOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway
- (2010) Antonio Russo et al. ONCOLOGY
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- Mixed Ovarian Epithelial Carcinomas With Clear Cell and Serous Components are Variants of High-grade Serous Carcinoma
- (2009) Guangming Han et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
- (2009) Jessica N McAlpine et al. BMC CANCER
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications
- (2009) Martin Köbel et al. GYNECOLOGIC ONCOLOGY
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
- (2009) C. Blake Gilks Journal of Oncology
- A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
- (2008) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
- (2008) Ashok R. Venkitaraman Annual Review of Pathology-Mechanisms of Disease
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study
- (2008) Sandro Pignata et al. BMC CANCER
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Critical molecular abnormalities in high-grade serous carcinoma of the ovary
- (2008) Martin Köbel et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
- (2008) C. Blake Gilks et al. HUMAN PATHOLOGY
- WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis
- (2008) C.J.R. Stewart et al. PATHOLOGY
- The impact of p53 and p73 on aneuploidy and cancer
- (2008) Richard Tomasini et al. TRENDS IN CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started